Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery

被引：56

作者：

Dietrich, W ^{[1
]}

Spannagl, M

机构：

[1] German Heart Ctr, Dept Anesthesiol, D-8000 Munich, Germany

[2] Univ Munich, Dept Hematol, Munich, Germany

来源：

ANESTHESIA AND ANALGESIA | 2002年 / 94卷 / 05期

关键词：

D O I：

10.1097/00000539-200205000-00070

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

页码：1369 / 1370

页数：2

共 11 条

[1] Update on the management of acute coronary syndromes [J].

Cohen, M .

CARDIOLOGY, 2000, 93 (04) :210-219

[2]

EMOFSSON M, 1997, J THORAC CARDIOVASC, V113, P576

[3]

Friederich PW, 2001, CIRCULATION, V103, P2555

[4] An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII [J].

Hendriks, HGD ;

van der Maaten, JMAA ;

de Wolf, J ;

Waterbolk, TW ;

Slooff, MJH ;

van der Meer, J .

ANESTHESIA AND ANALGESIA, 2001, 93 (02) :287-289

[5]

KENET G, 1999, LANCET, P354

[6]

Levy JH, 1999, J CARDIOTHOR VASC AN, V13, P6

[7] Platelet activity of high-dose factor VIIa is independent of tissue factor [J].

Monroe, DM ;

Hoffman, M ;

Oliver, JA ;

Roberts, HR .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (03) :542-547

[8] Direct activation of factor X by monocytes occurs during cardiopulmonary bypass [J].

Parratt, R ;

Hunt, BJ .

BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (01) :40-46

[9] Acute myocardial infarction following administration of recombinant activated factor VII (Novo seven) in a patient with haemophilia A and inhibitor [J].

Peerlinck, K ;

Vermylen, J .

THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) :1775-1776

[10] Aprotinin - An update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery [J].

Peters, DC ;

Noble, S .

DRUGS, 1999, 57 (02) :233-260

← 1 2 →